Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Juniper Pharmaceuticals Inc (NASDAQ:JNP)

6.93
Delayed Data
As of 3:59pm ET
 +0.03 / +0.43%
Today’s Change
5.30
Today|||52-Week Range
15.44
-32.72%
Year-to-Date
Cardiome Pharma (CRME) Jumps: Stock Moves 8.1% Higher
May 23 / Zacks.com - Paid Partner Content
Dermira (DERM) in Focus: Stock Gains 8.7% in Session
May 17 / Zacks.com - Paid Partner Content
Alcobra (ADHD) Catches Eye: Stock Adds 6.3% in Session
May 20 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close6.90
Today’s open7.04
Day’s range6.67 - 7.04
Volume33,113
Average volume (3 months)24,671
Market cap$74.5M
Dividend yield--
Data as of 3:59pm ET, 05/26/2016

Growth & Valuation

Earnings growth (last year)-174.07%
Earnings growth (this year)+51.67%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+15.69%
P/E ratioNM
Price/Sales2.95
Price/Book1.89

Competitors

 Today’s
change
Today’s
% change
CPIXCumberland Pharmaceu...+0.01+0.22%
CHMAChiasma Inc-0.09-2.89%
REPHRecro Pharma Inc+0.38+4.92%
ZYNEZynerba Pharmaceutic...-0.31-3.92%
Data as of 4:00pm ET, 05/26/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$37.6M
Annual profit (last year)-$2.1M
Net profit margin-5.68%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Frank C. Condella
Chief Operating Officer &
Director
Nikin Patel
Corporate headquarters
Boston, Massachusetts

Forecasts

Partner Offers

Search for Jobs